
|Videos|November 14, 2013
Formulary Analysis of Biosimilars: What Will the Process Involve?
The process of adding biosimilars to formularies will be much more rigorous than what the industry is accustomed to seeing in the generic molecule space, asserted Steven Lucio, senior director, Clinical Solutions and Pharmacy Program Development at Novation.
Advertisement
The process of adding biosimilars to formularies will be much more rigorous than what the industry is accustomed to seeing in the generic molecule space, asserted Steven Lucio, senior director, Clinical Solutions and Pharmacy Program Development at Novation.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
2
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
3
Navigating the New Era of Hemophilia Care: Insights From the Pharmacy Times Peer Exchange
4
From Implantable CGM to Continuous Ketone Monitoring: How New Technology Is Transforming Diabetes Care
5





































































































































